Home : DrugWatch : Sutent : News Articles

Sutent - News Articles

Cancer campaigner Clive faces surgery (From Oxford Mail): He has since fought successfully to make the kidney cancer drug Sunitinib available on the NHS and last month persuaded the Government to allocate £200m to ...
UroToday - Please Login - Efficacy and safety of sunitinib on metastatic renal cell carcinoma: A single-institution experience - Abstract: We assessed the efficacy and safety of the tyrosine kinase inhibitor sunitinib in Korean patients with metastatic renal cell carcinoma (mRCC). ...
Georgetown University: While they specifically tested a new chemotherapy called Sutent, the study applies to about half of all cancer drugs that use the same enzymes. ...
UroToday - Please Login - Pazopanib: A multikinase inhibitor with activity in advanced renal cell carcinoma - Abstract: Three of these new agents are multitargeted kinase inhibitors, including sunitinib, sorafenib, and recently pazopanib, two target the mTOR (temsirolimus and ...
UroToday - Please Login - Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma - Abstract: To identify factors that can be used to identify metastatic clear cell RCC patients more likely to benefit from sequential sunitinib. ...
UroToday - Please Login - Management of sunitinib-related adverse events: An evidence- and expert-based consensus approach - Abstract: Based on its clinical activity, disease control over a period of 11 months can be expected with sunitinib treatment. Given this prolonged period of exposure ...
BBC News - Funeral for Kent Sunitinib drug battle cancer woman: Nikki Phelps, 37, of Luddesdown, won an appeal in April against a decision by NHS West Kent not to pay for the drug Sunitinib, but died on 11 May. The former teacher had been suffering from a rare form of glandular cancer. Rev Canon ...
Sunitinib plus docetaxel not recommended for newly diagnosed breast cancer | HemOncToday: CHICAGO — A study examining the combination of the antiangiogenic agent sunitinib and docetaxel failed to meet its primary endpoint in women with newly ...

Drug firm praised over cancer compassion - Yorkshire Post: Ian Bowers, 41, was diagnosed with a rare endocrine system cancer in January 2008 and was told the drug Sutent could help him. About £12000 was raised and ...
Data do not support sunitinib/capecitabine combo for advanced breast cancer | HemOncToday: presented data from the trial, which sought to investigate the antiangiogenic agent, sunitinib (Sutent, Pfizer), in combination with chemotherapy. ...
Sunitinib rechallenge benefited select metastatic renal cell carcinomas | HemOncToday: Sunitinib rechallenge has potential as a treatment option in select patients with favorable- or intermediate-risk metastatic renal cell carcinoma, ...
News - Hypertension May Be Biomarker for Sunitinib Efficacy: Presented at ASCO-GU: SAN FRANCISCO -- March 8, 2010 -- Clinicians' view of hypertension associated with sunitinib treatment may be changing. While elevated blood pressure associated with the use of sunitinib and other vascular endothelial growth factor (VEGF) agents has ...
IGF-receptor inhibitor and sunitinib show activity in stage IV pancreatic cancer - Cancer Network: The final analysis of an international phase III trial found that sunitinib (Sutent) significantly prolonged both overall survival (OS) and progression-free survival (PFS) in patients with advanced pancreatic neuroendocrine tumors (NET). In fact, the study was stopped early ...
15 years old cancer patient “Dillon Claxton” and family shares their journey through Cancer.: Mrs. Claxton disclosed that presently Dillon is on a treatment called Sutent “a chemo which is in a tablet form, he takes the treatment everyday to kill the cancer cells and he would be taking it for a year. She disclosed that the Sutent tablets that her ...
Survival with Sutent: A costly cancer 'miracle' - FiercePharma: Ever wonder how the cancer drug Sutent made it to market? Barely, according to a behind-the-scenes piece from Bloomberg. The drug almost hit the R&D discard pile back in 2003, said Dr. George Demetri, an oncologist who was involved in testing it. It was a ...
Cancer sufferer's 'minor miracle' - Buxton Today: Specialised radiotherapy didn't work so his only option was a drug called Sutent, which is approved in the UK for treating kidney cancer but not Ian's ...

Want to contact a District of Columbia Sutent lawyer? ...Get a free case evaluation from one of our District of Columbia Sutent lawyers now.

Need A Sutent Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Sutent Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Sutent Information

Click to View Our Legal Resources

Want to contact a District of Columbia Sutent lawyer? ...Get a free case evaluation from one of our District of Columbia Sutent lawyers now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-092335

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Sutent Click to select a Legal Issue

Close (x)

Find Legal Help for Your Sutent Case - Submit Your Information Below

Do you need legal assistance with your Sutent case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Sutent Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.